Clarus Therapeutics Holdings
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Total operating expenses were $50,969,000.
Profit Margin
| 2020 | 0 | 0 | |
|---|---|---|---|
| 2021 | 13.95M | -56.51M | -404.9% |
CRXT Income Statement (2020 – 2021)
| 2021 | 2020 | |
|---|---|---|
Revenue | ||
Revenue | 13.95M | 0 |
Cost of revenue | 2.72M | 0 |
Gross profit | 11.23M | 0 |
Operating exp. | ||
Research and development | 3.63M | 0 |
Selling and marketing | 30.67M | 0 |
Total operating expenses | 50.96M | 2.97M |
Operating income | -24.72M | -47.17M |
Other income (expenses), net | -15.89M | 0 |
Income before tax | -40.61M | 0 |
Income tax expense | 15.89M | 0 |
Net income | -56.51M | 0 |
Earnings per share | ||
Basic EPS | -2.35 | 0 |
Diluted EPS | -2.35 | 0 |
| Data source | Data source |